Unknown

Dataset Information

0

A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.


ABSTRACT: Parathyroid hormone-related protein (PTHrP)(1-36) increases lumbar spine (LS) bone mineral density (BMD), acting as an anabolic agent when injected intermittently, but it has not been directly compared with parathyroid hormone (PTH)(1-34). We performed a 3-month randomized, prospective study in 105 postmenopausal women with low bone density or osteoporosis, comparing daily subcutaneous injections of PTHrP(1-36) to PTH(1-34). Thirty-five women were randomized to each of three groups: PTHrP(1-36) 400?µg/day; PTHrP(1-36) 600?µg/day; and PTH(1-34) 20?µg/day. The primary outcome measures were changes in amino-terminal telopeptides of procollagen 1 (PINP) and carboxy-terminal telopeptides of collagen 1 (CTX). Secondary measures included safety parameters, 1,25(OH)2 vitamin D, and BMD. The increase in bone resorption (CTX) by PTH(1-34) (92%) (p?

SUBMITTER: Horwitz MJ 

PROVIDER: S-EPMC3789852 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.

Horwitz Mara J MJ   Augustine Marilyn M   Khan Leila L   Martin Emily E   Oakley Christine C CC   Carneiro Raquel M RM   Tedesco Mary Beth MB   Laslavic Angela A   Sereika Susan M SM   Bisello Alessandro A   Garcia-Ocaña Adolfo A   Gundberg Caren M CM   Cauley Jane A JA   Stewart Andrew F AF  

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20131101 11


Parathyroid hormone-related protein (PTHrP)(1-36) increases lumbar spine (LS) bone mineral density (BMD), acting as an anabolic agent when injected intermittently, but it has not been directly compared with parathyroid hormone (PTH)(1-34). We performed a 3-month randomized, prospective study in 105 postmenopausal women with low bone density or osteoporosis, comparing daily subcutaneous injections of PTHrP(1-36) to PTH(1-34). Thirty-five women were randomized to each of three groups: PTHrP(1-36)  ...[more]

Similar Datasets

| S-EPMC2597917 | biostudies-literature
| S-EPMC4860360 | biostudies-literature
| S-EPMC5193000 | biostudies-literature
| S-EPMC8661154 | biostudies-literature
| S-EPMC8514385 | biostudies-literature
| S-EPMC7429307 | biostudies-literature
| S-EPMC9202729 | biostudies-literature
| S-EPMC3844872 | biostudies-literature
| S-EPMC6232230 | biostudies-literature
| S-EPMC4162466 | biostudies-other